from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0159c/PE3

LFCtreatmentdescriptionclass of inhibitor

0.141

Amikacinug/mL Amikacintranslation

1.397

Cap5-10ug/mL Capreomycintranslation

0.891

Rox10-50 ug/mL Roxithromycintranslation

0.095

SM2-5 ug/mL Streptomycintranslation

0.517

Tet5-10 ug/mL Tetracyclinetranslation

-0.740

Rif0.2-5ug/mL Rifampicintranscription

0.311

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.728

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.633

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.083

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.559

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.527

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.623

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.701

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.233

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.236

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.748

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.678

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.095

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.546

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.224

KCN5-20 ug/mL Potassium cyaniderespiration

0.667

NaN30.2-2 mM Sodium aziderespiration

-0.815

Nigericin50 uM Nigericinrespiration

0.041

TRC10-150 ug/mL Triclosanrespiration

0.747

TRZ10-25 ug/mL Thioridazinerespiration

-1.084

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.887

menadione6-10 ug/mL Menadionerespiration

-0.085

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.591

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.166

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.108

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.902

NRP_1Non-replicating persistence stage 1dosRassociated

0.046

Amp0.2mg/mL AmpicillincellWall

0.067

Cephalexin20-100 ug/mL CephalexincellWall

1.155

Cerulenin0.32-5 ug/mL CerulenincellWall

0.268

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.215

EMB10-20 ug/mL EthambutolcellWall

0.113

Eta12-40 ug/mL EthionamidecellWall

0.155

INH0.2-0.4 ug/mL IsoniazidcellWall

0.010

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.270

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.478

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.023

BZA0.12 mg/mL BenzamidearomaticAmides

-0.328

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.542

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.333

H2O24 mM hydrogen peroxideDNAdamaging

0.383

Levo10 ug/mL LevofloxacinDNAdamaging

-0.039

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.960

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.587

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.092

UVUV-irradiationDNAdamaging

-0.391

ARP41-4 ug/mL Antitubercular compound ARP4?

0.830

Antimycin12.5-50 ug/mL Antimycin A?

0.273

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.188

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.342

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.556

PA8240.2-2 ug/mL PA-824?

-0.067

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.339

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.233

Verapamil50 uM Verapamil?

-0.163

mercaptoethanol2 mM 2-Mercaptoethanol?

0.030

methoxatin10-20 ug/mL Methoxatin?